Albireo Pharma Total Liabilities

Albireo Pharma (ALBO) currently reports a total liabilities of $220M as of September 2022. That compares with $110M in the prior-year period — up 92.8% year over year. Use the charts on this page to explore Albireo Pharma's total liabilities history and peer comparisons.

Albireo Pharma's total liabilities increased from $110M to $220M — a 92.8% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Albireo Pharma reported $220M in total liabilities as of September 2022. That compares with $110M in the prior-year period — up 92.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Albireo Pharma, and consider following ALBO for alerts when major investors trade the stock.

Albireo Pharma is classified in the Healthcare sector. On total liabilities, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALBO with unrelated industries.